abstract |
FIELD: non-alcoholic steatohepatitis treatment.SUBSTANCE: invention relates to 2-[(1R,3r,5S)-3-({5-cyclopropyl-3-[2-(trifluoromethoxy) phenyl]-1,2-oxazole-4-yl}methoxy)-8-azabicyclo[3.2.1]octane-8-yl]-4-fluorine-1,3-benzothiazole-6-carboxylic acid for non-alcoholic steatohepatitis treatment (NASH), where the specified compound should be injected at doses of 10 mcg, 30 mcg, 60 mcg, 90 mcg, 120 mcg.EFFECT: non-alcoholic steatohepatitis treatment.5 cl, 5 ex, 5 tbl, 5 dwg |